The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Children's Hospital and Pitt lead national trial of hypothermia to treat pediatric brain injury

PITTSBURGH May 17, 2007 A renowned Children's Hospital of Pittsburgh of UPMC neurosurgeon will lead a $11.5 million National Institutes of Health-funded clinical trial examining the effectiveness of induced hypothermia as a therapy for brain swelling in children who have suffered traumatic brain injuries.

P. David Adelson, MD, director of the Pediatric Neurotrauma Center at Children's and the A. Leland Albright Professor of Neurosurgery at the University of Pittsburgh School of Medicine, will lead researchers at 12 sites throughout the country.

Researchers plan to enroll 340 children up to age 16 in the five-year, Phase III randomized trial, which is being funded by the National Institute of Neurological Disorders and Stroke. In Pittsburgh, Children's will serve as the clinical site for the study and Pitt will serve as the coordinating site.

A previous Phase II clinical trial of induced hypothermia therapy led by Dr. Adelson at Children's found that moderate hypothermia therapy is safe and may potentially improve outcome. Results of that study were published in the journal Neurosurgery in April 2005.

"We've proven this therapy is safe. Now if we can determine that it is effective, it would be a major breakthrough because currently there are very limited treatments that improve outcome following traumatic brain injury in children," Dr. Adelson said. "The belief is that cooling impacts the cascade of events that leads to brain swelling. Reducing brain swelling potentially could prevent further injury."

Patients in the study selected to receive hypothermia therapy will be cooled to between 3233 degrees Celsius (8990 degrees Fahrenheit), using special cooling blankets and/or cooled saline injected intravenously. They will be cooled for 48 hours and then followed by researchers for one year to track outcomes, with a battery of tests being conducted at six and 12 months following injury.


'"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
17-May-2007


Page: 1

Related medicine news :

1. Support for Childrens Health and Medicare Protection Act given to House leaders by ACP
2. Childrens brain responses predict impact of sleep loss on attention
3. Childrens Hospital Boston presents at the American College of Cardiology Scientific Sessions
4. Childrens packed lunches: Are they even worse than Turkey Twizzlers?
5. Childrens Hospital Oakland Research Institute -- cancer study
6. Childrens Hospital Boston neurosurgeons to perform brain tumor removal during live Web cast
7. Study by Childrens Hospital and Carnegie Mellon explains crucial deficit in children with autism
8. Ear infection expert from Childrens Hospital of Pittsburgh leads interactive demo on diagnosis
9. Cincinnati Childrens researchers publish findings on potential target for leukemia treatment
10. Childrens Hospital of Pittsburgh and UPMC surgeons save two lives with domino transplant
11. Johns Hopkins Childrens Center to lead largest-ever study on kidney disease in children

Post Your Comments:
(Date:11/23/2009)...-James.G.Schwade,M.D.announcesthenewlyenhancedCybe...rKnifeCenterofMiami,( www.cyberknifemiami.com )....targetedintensedoseofradiationthatkillscancercells...mentcanlastfrom30minutestoonehour,andisusuallycomp...eatmentCenterintheSoutheasternU.S.,theMiamifacilit...
(Date:11/23/2009)...thin one year of starting to have sex, CDC report ...) -- As many as one in four U.S. teenage girls hav...nfected soon after their first sexual encounter, a...n of STDs among teen girls reminds us that we can,...lieb, from the division of sexually transmitted di...
(Date:11/23/2009)...ege of Georgia is leading an initiative that could...s with sickle cell disease. , Morehouse Univers...re partners in the initiative that is enlisting pr...medical homes" for patients, changing how patients...hospital and seeking better prevention and treatme...
(Date:11/23/2009)...ire-FirstCall/--InstacareCorp.(OTCBulletinBoard:IS...d ,target=,_blank,title=, MD@Hand ,> MD@Hand ,tar..., MD@Hand ,> MD@Hand ,> MD@Hand ,target=,_blank,t..., MD@Hand ,target=,_blank,title=, MD@Hand ,> MD@Ha...k,title=, MD@Hand ,> MD@Hand ,> MD@Hand ,target=,...
(Date:11/23/2009)...ire/--Thanksgivingweekendmarksthe36thannualStateFa...icrepresentsthesportsmanshipandprideoftwoschoolsbu...hoseinattendance. ,, ForthecrewofthenewU.S.Coas...mebeforetheyworktotestandlaunchabrandnewshiptoprot...ttyOfficerClaudeBovellandtherestofthecrewwillbegin...
Breaking Medicine News(10 mins):Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7Health News:Nothing Is Like Being There 2
(Date:11/23/2009)...23/PRNewswire-FirstCall/--CeptionTherapeutics,Inc....n,Inc.(Nasdaq: CEPH )todayannouncedresultsfromaPha...atreatmentforpediatriceosinophilicesophagitis(EoE)...rimaryendpointsofchangesinesophagealeosinophilleve...atpatientstreatedwithCINQUILshowedastatisticallysi...
(Date:11/23/2009)...re/--AdvancedSterilizationProducts(ASP),aleadinggl...odaytheacquisitionbyitsFrenchaffiliate,ApsisS.A.S....vedisinfectionprocessesandtechnologiestopreventhea...renotdisclosed. ,, GlosterEuropedesignsandmarke...videsdisinfectionofpatientenvironmentssuchashospit...
(Date:11/20/2009)...wire/ -- The United States Court of Appeals for t...ruling yesterday, approving a settlement in the lo...tical litigation against AstraZeneca Pharmaceutica...i-bin/prnh/20080317/AQM144LOGO ) ,, The ruling ...rchased the pharmaceutical giant,s prostate cancer...
Breaking Medicine Technology:Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3SXC Health Solutions announces pricing of upsized public offering of common shares 57606 1SXC Health Solutions announces pricing of upsized public offering of common shares 57606 2SXC Health Solutions announces pricing of upsized public offering of common shares 57606 3SXC Health Solutions announces pricing of upsized public offering of common shares 57606 4SXC Health Solutions announces pricing of upsized public offering of common shares 57606 5You Gotta Wash Your Hands is the Word Out 21 57601 1You Gotta Wash Your Hands is the Word Out 21 57601 2Amgen to Present at the UBS Global Life Sciences Conference 57597 1Amgen to Present at the UBS Global Life Sciences Conference 57597 2
Other News:
...t is important that doctors have the ability to re...illnesses, in case it is reintroduced, state the a...ncet.......The World Health Organization (WHO) dec...n over the potential use of the virus by terrorist...
...e cancer - black men with a family history - are t...ages of risk, researchers say.......Only 25 percen...ned using the common blood test that measures pros...nual digital rectal exams, according to a study pu...
...porting non-profit of the Association for Research...ay that the research presented at the inaugural AR..."Ocular versus Extraocular Neovascularization: Mir...hed online and in print in the February 2006 issue...
...sity lipoprotein cholesterol (LDL-C) levels higher...tional Institutes of Health.......Of that group, 3...ut them at increased risk for cardiovascular disea... co-researchers at Northwestern University Feinber...
health news:High-risk black men are screened less for prostate cancer 2health news:Gap widens between optimal versus actual cholesterol levels 2
...ent tuberculosis infections in... non-U.S.-born re...h rate of the active disease in this population, a...last decade by researchers at Columbia Universitys...ol of Public Health, the Public Health Research In...
...ni has given Columbia University $2.75 million to ...disorders, such as Alzheimers disease and Parkinso... expression in brain tissue. ... ...cades that advances in medicine that promote longe...
SEVILLE, Spain, World Federation of Haemophilia Congress, May 21, 2002 -- Baxter BioScience today announced the launch of the BAXJECT needleless transfer device (BAXJECT), a safer, faster and easier w
...yeth Pharmaceuticals, a division of Wyeth (NYSE:WY...th depression maintained remission of their sympto...from their disease, after a year of therapy with t...cording to data from a multicenter trial presented...
health news:More preventive tuberculosis treatment should reduce cases in non-US-born 2health news:More preventive tuberculosis treatment should reduce cases in non-US-born 3health news:More preventive tuberculosis treatment should reduce cases in non-US-born 4health news:Columbia University receives $2.75 million for Alzheimer's and Parkinson's disease research 2health news:Baxter introduces Baxject needleless transfer device at International Haemophilia Congress 2health news:Baxter introduces Baxject needleless transfer device at International Haemophilia Congress 3health news:Effexor (R) XR achieved long-term remission in 67 percent of recurring depression patients 2health news:Effexor (R) XR achieved long-term remission in 67 percent of recurring depression patients 3